MRI of transgene expression: Correlation to therapeutic gene expression

Neoplasia

Volumn 4, Issue 6, 2002, Pages 523-530

  Ichikawa, Tomotsugu ^a   Högemann, Dagmar ^a   Saeki, Yoshinaga ^a   Tyminski, Edyta ^a   Terada, Kinya ^a   Weissleder, Ralph ^a   Chiocca, E Antonio ^a   Basilion, James P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amplicon; CLIO; ETR; MRI; Transgene

Indexed keywords

GENE PRODUCT; TRANSFERRIN RECEPTOR; CONTRAST MEDIUM; CYTOCHROME P450; IRON; OXIDE;

AMPLICON; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DNA VECTOR; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; GENE THERAPY; GENETIC ENGINEERING AND GENE TECHNOLOGY; GLIOMA CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSGENE; ANIMAL; BRAIN TUMOR; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; ENZYME IMMUNOASSAY; GENE TRANSFER; GENE VECTOR; GENETIC MARKER; GENETIC TRANSDUCTION; GENETICS; GLIOMA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; METABOLISM; MOLECULAR PROBE; MOUSE; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE; RETROVIRUS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL SURVIVAL; CONTRAST MEDIA; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, ERBB-1; GENETIC MARKERS; GENETIC VECTORS; GLIOMA; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; IRON; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR PROBES; OXIDES; RECEPTORS, TRANSFERRIN; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0036859888     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900266     Document Type: Article

References (37)

1. Rainov NG, Sena-Esteves M, Fraefel C, Dobberstein KU, Chiocca EA, and Breakefield XO (1998). A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma. Adv Exp Med Biol 451: 393-403.
2. Runnebaum IB (1997). Basics of cancer gene therapy. Anticancer Res 17: 2887-90.
3. Zwacka RM, and Dunlop MG (1998). Gene therapy for colon cancer. Hematol Oncol Clin North Am 12: 595-615.
4. Ikeda K, Ichikawa T, Wakimoto H, Silver J, Deisboeck T, Finkelstein D, Harsh GI, Louis D, Bartus R, Hochberg F, and Chiocca E (1999). Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med 5: 881-87.
5. Carter BS, Zervas NT, and Chiocca EA (1999). Neurogenetic surgery: Current limitations and the promise of gene- and virus-based therapies. Clin Neurosurg 45: 226-46 (in process citation).
6. Chung RY, Saeki Y, and Chiocca EA (1999). B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells. J Virol 73: 7556-64.
7. Markert J (2000). Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase 1 trial. Gene Ther 7: 867-74.
8. Sandmair AM, Loimas S, Puranen P, Immonen A, Kossila M, Puranen M, Hurskainen H, Tyynela K, Turunen M, Vanninen R, Lehtolainen P, Paljarvi L, Johansson R, Vapalahti M, and Yla-Herttuala S (2000). Thymidine kinase gene therapy for human malignant glioma, using replication -deficient retroviruses or adenoviruses. Hum Gene Ther 11: 2197-205.
9. Klatzmann D, Cherin P, Bensimon G, Boyer O, Coutellier A, Charlotte F, Boccaccio C, Salzmann JL, and Herson S (1998). A phase I/II doseescalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma. Study group on gene therapy of metastatic melanoma. Hum Gene Ther 9: 2585-94 (in process citation).
10. Harsh GR, Deisboeck TS, Louis DN, Hilton J, Colvin M, Silver JS, Qureshi NH, Kracher J, Finkelstein D, Chiocca EA, and Hochberg FH (2000). Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: A gene-marking and neuropathological study. J Neurosurg 92: 804-11.
11. Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, Toyokuni T, Phelps ME, Larson SM, Balatoni J, Finn R, Sadelain M, Tjuvajev J, and Blasberg R (2000). Imaging transgene expression with radionuclide imaging technologies. Neoplasia (New York) 2: 118-38.
12. Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, Ballon D, Koutcher J, Finn R, Woo SL, and Blasberg RG (1999). Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res 59: 5186-93.
13. Wunderbaldinger P, Bogdanov A, and Weissleder R (2000). New approaches for imaging in gene therapy. Eur J Radiol 34: 156-65.
14. Bremer C, and Weissleder R (2001). In vivo imaging of gene expression. Acad Radiol 8: 15-23 (see comments).
15. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, and Heiss W (2001). Positronemission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358: 727-29.
16. Rehemtulla A, Hall DE, Stegman LD, Prasad U, Chen G, Bhojani MS, Chenevert TL, and Ross BD (2002). Molecular imaging of gene expression and efficacy following adenoviral-mediated tumor gene therapy. Mol Imaging 1: 43-55.
17. 1H magnetic resonance spectroscopic studies. BrJ Cancer 79: 278-85.
18. Stegman LD, Rehemtulla A, Beattie B, Kievit E, Lawrence TS, Blasberg R, Tjuvajev J, and Ross BD (1999). Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenographs with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci 96: 9821-26.
19. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, and Basilion JP (2000). In vivo magnetic resonance imaging of transgene expression. Nat Med 6: 351-55.
20. Moore A, Basilion J, Chiocca A, and Weissleder R (1998). Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta 1402: 239-49.
21. H6gemann D, Josephson L, Weissleder R, and Basilion JP (2000). Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem 11: 941-46 (in process citation).
22. Nagane M, Coufal F, Lin H, Bogler O, Cavenee WK, and Huang HJ (1996). A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 56: 5079-86.
23. Niwa H, Yamamura K, and Miyazaki J (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-99.
24. Saeki Y, Ichikawa T, Saeki A, Chiocca EA, Tobler K, Ackermann M, Breakefield XO, and Fraefel C (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coll: Rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther 9: 2787-94.
25. Saeki Y, Fraefel C, Ichikawa T, Breakefield XO, and Chiocca EA (2001). Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV - 1 DNA in a bacterial artificial chromosome. Mol Ther J Am Soc Gene Ther 3: 591-601.
26. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, and Huang HJ (1994). A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 91: 7727-31.
27. Rutledge EA, Gaston I, Root BJ, McGraw TE, and Enns CA (1998). The transferrin receptor cytoplasmic domain determines its rate of transport through the biosynthetic pathway and its susceptibility to cleavage early in the pathway. J Biol Chem 273: 12169-75.
28. Fraefel C, Breakefield XO, and Jacoby D (1998). In HSV-1 Amplicon in Gene Therapy for Neurological Disorders and Brain Tumors. E Chlocca, and X Breakefield (Eds). Humana Press, Totowa, NJ. pp. 63-82.
29. Eriksson LC, Torndal UB, and Andersson GN (1986). The transferrin receptor in hepatocyte nodules: Binding properties, subcellular distribution and endocytosis. Carcinogenesis 7: 1467-74.
30. Lamb JE, Ray F, Ward JH, Kushner JP, and Kaplan J (1983). Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells. J Biol Chem 258: 8751-58.
31. Wei MX, Tamiya T, Chase M, Boviatsis EJ, Chang TK, Kowall NW, Hochberg FH, Waxman DJ, Breakefield XO, and Chlocca EA (1994). Experimental tumor therapy in mice using the cyclophosphamideactivating cytochrome P450 2B1 gene. Hum Gene Ther 5: 969-78.
32. Monier S, Van Luc P, Kreibich G, Sabatini DD, and Adesnik M (1988). Signals for the incorporation and orientation of cytochrome P450 in the endoplasmic reticulum membrane. J Cell Biol 107; 457-70.
33. Wade-Martins R, Smith ER, Tyminski E, Chiocca EA, and Saeki Y (2001). An Infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat Biotechnol 19: 1067-70.
34. Geller AI, and Breakefield XO (1988). A defective HSV-1 vector expresses Escherichia coli beta -galactosidase in cultured peripheral neurons. Science 241: 1667-69.
35. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, and Lewis J (1989). Superparamagnetic iron oxide: Pharmacokinetics and toxicity. AJR, Am J Roentgenol 152: 167-73.
36. Tjuvajev JG, Joshi A, Callegari J, Lindsley L, Joshl R, Balatoni J, Finn R, Larson SM, Sadelain M, and Blasberg RG (1999). A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia (New York) 1: 315-20.
37. Yaghoubi SS, Wu L, Liang Q, Toyokuni T, Barrio JR, Namavari N, Satyamurthy N, Phelps ME, Herschman HR, and Gambhir SS (2001). Direct correlation between positron emission tomographic images of two reporter genes delivered by distinct adenoviral vectors. Gene Ther 8: 1072-80.